Related Experiment Video
Updated: Jul 16, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Intracellular BAPTA directly inhibits PFKFB3, thereby impeding mTORC1-driven Mcl-1 translation and killing
Flore Sneyers1, Martijn Kerkhofs1, Femke Speelman-Rooms1,2
1KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, Campus Gasthuisberg O&N I, Herestraat 49 box 802, 3000, Leuven, Belgium.
Abstract:
Intracellular Ca2+ signals control several physiological and pathophysiological processes. The main tool to chelate intracellular Ca2+ is intracellular BAPTA (BAPTAi), usually introduced into cells as a membrane-permeant acetoxymethyl ester (BAPTA-AM). Previously, we demonstrated that BAPTAi enhanced apoptosis induced by venetoclax, a BCL-2 antagonist, in diffuse large B-cell lymphoma (DLBCL). This finding implied a novel interplay between intracellular Ca2+ signaling and anti-apoptotic BCL-2 function. Hence, we set out to identify the underlying mechanisms by which BAPTAi enhances cell death in B-cell cancers. In this study, we discovered that BAPTAi alone induced apoptosis in hematological cancer cell lines that were highly sensitive to S63845, an MCL-1 antagonist. BAPTAi provoked a rapid decline in MCL-1-protein levels by inhibiting mTORC1-driven Mcl-1 translation. These events were not a consequence of cell death, as BAX/BAK-deficient cancer cells exhibited similar downregulation of mTORC1 activity and MCL-1-protein levels. Next, we investigated how BAPTAi diminished mTORC1 activity and identified its ability to impair glycolysis by directly inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) activity, a previously unknown effect of BAPTAi. Notably, these effects were also induced by a BAPTAi analog with low affinity for Ca2+. Consequently, our findings uncover PFKFB3 inhibition as an Ca2+-independent mechanism through which BAPTAi impairs cellular metabolism and ultimately compromises the survival of MCL-1-dependent cancer cells. These findings hold two important implications. Firstly, the direct inhibition of PFKFB3 emerges as a key regulator of mTORC1 activity and a promising target in MCL-1-dependent cancers. Secondly, cellular effects caused by BAPTAi are not necessarily related to Ca2+ signaling. Our data support the need for a reassessment of the role of Ca2+ in cellular processes when findings were based on the use of BAPTAi.
Insights
Intracellular BAPTA (BAPTAi) triggers apoptosis in MCL-1-dependent cancers by inhibiting glycolysis via PFKFB3, independent of Ca2+ signaling. This reveals PFKFB3 as a potential therapeutic target in these cancers.
Area of Science:
- Cellular Biology
- Cancer Research
- Biochemistry
Background:
- Intracellular calcium (Ca2+) signals regulate vital cellular functions.
- Intracellular BAPTA (BAPTAi) chelates Ca2+ and was previously shown to enhance venetoclax-induced apoptosis in DLBCL.
- This suggested an interplay between Ca2+ signaling and anti-apoptotic BCL-2 family proteins.
Purpose of the Study:
- To elucidate the mechanisms by which BAPTAi enhances cell death in B-cell malignancies.
- To investigate the role of intracellular Ca2+ signaling in BAPTAi-mediated effects.
Main Methods:
- Investigated BAPTAi effects on hematological cancer cell lines, including BAX/BAK-deficient cells.
- Assessed MCL-1 protein levels, mTORC1 activity, and glycolysis.
- Examined the impact of BAPTAi and a low-affinity analog on PFKFB3 activity.
Main Results:
- BAPTAi induced apoptosis in MCL-1-dependent hematological cancer cells by reducing MCL-1 protein levels.
- This reduction was achieved by inhibiting mTORC1-driven Mcl-1 translation, independent of cell death.
- BAPTAi impaired glycolysis by directly inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) activity, a Ca2+-independent effect.
Conclusions:
- BAPTAi inhibits PFKFB3, leading to impaired cellular metabolism and apoptosis in MCL-1-dependent cancer cells.
- PFKFB3 inhibition represents a Ca2+-independent mechanism and a potential therapeutic target in these cancers.
- The cellular effects of BAPTAi are not solely attributable to Ca2+ chelation, necessitating a re-evaluation of Ca2+'s role in studies using BAPTAi.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Abnormal Proliferation